Peroxisomes are organelles that are best known for their role in cellular lipid and hydrogen peroxide (H2O2) metabolism. Emerging evidence suggests that these organelles serve as guardians and modulators of cellular redox balance, and that alterations in their redox metabolism may contribute to aging and the development of chronic diseases such as neurodegeneration, diabetes, and cancer.
Recent Advances:
H2O2 is an important signaling messenger that controls many cellular processes by modulating protein activity through cysteine oxidation. Somewhat surprisingly, the potential involvement of peroxisomes in H2O2-mediated signaling processes has been overlooked for a long time. However, recent advances in the development of live-cell approaches to monitor and modulate spatiotemporal fluxes in redox species at the subcellular level have opened up new avenues for research in redox biology and boosted interest in the concept of peroxisomes as redox signaling platforms.
Critical Issues:
This review first introduces the reader to what is known about the role of peroxisomes in cellular H2O2 production and clearance, with a focus on mammalian cells. Next, it briefly describes the benefits and drawbacks of current strategies used to investigate the complex interplay between peroxisome metabolism and cellular redox state. Furthermore, it integrates and critically evaluates literature dealing with the interrelationship between peroxisomal redox metabolism, cell signaling, and human disease.
Future Directions:
As the precise molecular mechanisms underlying many of these associations are still poorly understood, a key focus for future research should be the identification of primary targets for peroxisome-derived H2O2.
Get full access to this article
View all access options for this article.
References
1.
AbdoS, ShiY, OtoukeshA, GhoshA, LoCS, ChenierI, FilepJG, IngelfingerJR, ZhangSL, and ChanJS. Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice. Diabetes, 63: 3483–3493, 2014.
2.
AbrahamsenG, FanY, MatigianN, WaliG, BelletteB, SutharsanR, RajuJ, WoodSA, VeiversD, SueCM, and Mackay-SimA. A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations. Dis Model Mech, 6: 489–502, 2013.
3.
AhmadS, KhanH, ShahabU, RehmanS, RafiZ, KhanMY, AnsariA, SiddiquiZ, AshrafJM, AbdullahSM, HabibS, and UddinM. Protein oxidation: an overview of metabolism of sulphur containing amino acid, cysteine. Front Biosci, 9: 71–87, 2017.
4.
AhnJ, NowellS, McCannSE, YuJ, CarterL, LangNP, KadlubarFF, RatnasingheLD, and AmbrosoneCB. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev, 15: 1217–1222, 2006.
5.
AngelovaPR and AbramovAY. Functional role of mitochondrial reactive oxygen species in physiology. Free Radic Biol Med, 100: 81–85, 2016.
6.
AntonenkovVD, GrunauS, OhlmeierS, and HiltunenJK. Peroxisomes are oxidative organelles. Antioxid Redox Signal, 13: 525–537, 2010.
7.
AntunesF and CadenasE. Estimation of H2O2 gradients across biomembranes. FEBS Lett, 475: 121–126, 2000.
8.
ApanasetsO, GrouCP, Van VeldhovenPP, BreesC, WangB, NordgrenM, DodtG, AzevedoJE, and FransenM. PEX5, the shuttling import receptor for peroxisomal matrix proteins, is a redox-sensitive protein. Traffic, 15: 94–103, 2014.
9.
Appenzeller-HerzogC, BánhegyiG, BogeskiI, DaviesKJ, Delaunay-MoisanA, FormanHJ, GörlachA, KietzmannT, LaurindoF, MargittaiE, MeyerAJ, RiemerJ, RützlerM, SimmenT, SitiaR, ToledanoMB, and TouwIP. Transit of H2O2 across the endoplasmic reticulum membrane is not sluggish. Free Radic Biol Med, 94: 157–160, 2016.
10.
AutenRL and DavisJM. Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res, 66: 121–127, 2009.
11.
AvshalumovMV, BaoL, PatelJC, and RiceME. H2O2 signaling in the nigrostriatal dopamine pathway via ATP-sensitive potassium channels: issues and answers. Antioxid Redox Signal, 9: 219–231, 2007.
12.
BakerDJ, WijshakeT, TchkoniaT, LeBrasseurNK, ChildsBG, van de SluisB, KirklandJL, and van DeursenJM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature, 249: 232–236, 2011.
13.
BarlakaE, GalatouE, MellidisK, RavingerovaT, and LazouA. Role of pleiotropic properties of peroxisome proliferator-activated receptors in the heart: focus on the non-metabolic effects in cardiac protection. Cardiovasc Ther, 34: 37–48, 2016.
14.
BaumgartE, FahimiHD, StichA, and VölklA. L-lactate dehydrogenase A4- and A3B isoforms are bona fide peroxisomal enzymes in rat liver. Evidence for involvement in intraperoxisomal NADH reoxidation. J Biol Chem, 271: 3849–3855, 1996.
15.
BaumgartE, VanhorebeekI, GrabenbauerM, BorgersM, DeclercqPE, FahimiHD, and BaesM. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol, 159: 1477–1494, 2001.
BergerJ, Forss-PetterS, and EichlerFS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie, 98: 135–142, 2014.
18.
BergerJ, PujolA, AubourgP, and Forss-PetterS. Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy. Brain Pathol, 20: 845–856, 2010.
19.
BienertGP and ChaumontF. Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide. Biochim Biophys Acta, 1840: 1596–1604, 2014.
20.
BilanDS and BelousovVV. New tools for redox biology: from imaging to manipulation. Free Radic Biol Med, 109: 167–188, 2017.
21.
BottelbergsA, VerheijdenS, Van VeldhovenPP, JustW, DevosR, and BaesM. Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system. J Neuroinflammation, 9: 61, 2012.
22.
BoverisA, OshinoN, and ChanceB. The cellular production of hydrogen peroxide. Biochem J, 128: 617–663, 1972.
23.
BracalenteC, IbañezIL, BerensteinA, NotcovichC, CerdaMB, KlamtF, ChernomoretzA, and DuránH. Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated. Oncotarget, 7: 41154–41171, 2016.
24.
BrassEP. Overview of coenzyme A metabolism and its role in cellular toxicity. Chem Biol Interact, 90: 203–214, 1994.
25.
BrattA, RosenwasserS, MeyerA, and FluhrR. Organelle redox autonomy during environmental stress. Plant Cell Environ, 39: 1909–1919, 2016.
26.
BrewerTF, GarciaFJ, OnakCS, CarrollKS, and ChangCJ. Chemical approaches to discovery and study of sources and targets of hydrogen peroxide redox signaling through NADPH oxidase proteins. Annu Rev Biochem, 84: 765–790, 2015.
BrownMR, MillerFJJr., LiWG, EllingsonAN, MozenaJD, ChatterjeeP, EngelhardtJF, ZwackaRM, OberleyLW, FangX, SpectorAA, and WeintraubNL. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res, 85: 524–533, 1999.
29.
BulinaME, ChudakovDM, BritanovaOV, YanushevichYG, StaroverovDB, ChepurnykhTV, MerzlyakEM, ShkrobMA, LukyanovS, and LukyanovKA. A genetically encoded photosensitizer. Nat Biotechnol, 24: 95–99, 2006.
30.
CairnsRA, HarrisIS, and MakTW. Regulation of cancer cell metabolism. Nat Rev Cancer, 11: 85–95, 2011.
31.
CarterAB, TephlyLA, VenkataramanS, OberleyLW, ZhangY, BuettnerGR, SpitzDR, and HunninghakeGW. High levels of catalase and glutathione peroxidase activity dampen H2O2 signaling in human alveolar macrophages. Am J Respir Cell Mol Biol, 31: 43–53, 2004.
32.
CarvalhoAF, PintoMP, GrouCP, AlencastreIS, FransenM, Sá-MirandaC, and AzevedoJE. Ubiquitination of mammalian Pex5p, the peroxisomal import receptor. J Biol Chem, 282: 31267–31272, 2007.
33.
ChenHP, ZhaoYT, and ZhaoTC. Histone deacetylases and mechanisms of regulation of gene expression. Crit Rev Oncog, 20: 35–47, 2015.
34.
ChenX, LiangH, Van RemmenH, VijgJ, and RichardsonA. Catalase transgenic mice: characterization and sensitivity to oxidative stress. Arch Biochem Biophys, 422: 197–210, 2004.
35.
ChildsBG, DurikM, BakerDJ, and van DeursenJM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med, 21: 1424–1435, 2015.
36.
ChuS, HuangQ, AlvaresK, YeldandiAV, RaoMS, and ReddyJK. Transformation of mammalian cells by overexpressing H2O2-generating peroxisomal fatty acyl-CoA oxidase. Proc Natl Acad Sci USA, 92: 7080–7084, 1995.
37.
CipollaCM and LodhiIJ. Peroxisomal dysfunction in age-related diseases. Trends Endocrinol Metab, 28: 297–308, 2017.
38.
CraneDI. Revisiting the neuropathogenesis of Zellweger syndrome. Neurochem Int, 69: 1–8, 2014.
39.
CuiW, MaJ, WangX, YangW, ZhangJ, and JiQ. Free fatty acid induces endoplasmic reticulum stress and apoptosis of β-cells by Ca2+/calpain-2 pathways. PLoS One, 8: e59921, 2013.
40.
De DuveC and BaudhuinP. Peroxisomes (microbodies and related particles). Physiol Rev, 46: 323–357, 1966.
41.
DelmaghaniS, DefournyJ, AghaieA, BeurgM, DulonD, ThelenN, PerfettiniI, ZellesT, AllerM, MeyerA, EmptozA, GiraudetF, LeiboviciM, DartevelleS, SoubigouG, ThiryM, ViziES, SafieddineS, HardelinJP, AvanP, and PetitC. Hypervulnerability to sound exposure through impaired adaptive proliferation of peroxisomes. Cell, 163: 894–906, 2015.
42.
DelmaghaniS, del CastilloFJ, MichelV, LeiboviciM, AghaieA, RonU, Van LaerL, Ben-TalN, Van CampG, WeilD, LangaF, LathropM, AvanP, and PetitC. Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy. Nat Genet, 38: 770–778, 2006.
43.
DhaunsiGS and BitarMS. Antioxidants attenuate diabetes-induced activation of peroxisomal functions in the rat kidney. J Biomed Sci, 11: 566–570, 2004.
44.
DianoS. Role of reactive oxygen species in hypothalamic regulation energy metabolism. Endocrinol Metab (Seoul), 28: 3–5, 2013.
45.
DianoS, LiuZW, JeongJK, DietrichMO, RuanHB, KimE, SuyamaS, KellyK, GyengesiE, ArbiserJL, BelshamDD, SarrufDA, SchwartzMW, BennettAM, ShanabroughM, MobbsCV, YangX, GaoXB, and HorvathTL. Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat Med, 17: 1121–1127, 2011.
46.
DohertyJF, GoldenMH, and BrooksSE. Peroxisomes and the fatty liver of malnutrition: an hypothesis. Am J Clin Nutr, 54: 674–677, 1991.
47.
DouliasPT, TenopoulouM, GreeneJL, RajuK, and IschiropoulosH. Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. Sci Signal, 6: rs1, 2013.
48.
ElsnerM, GehrmannW, and LenzenS. Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells. Diabetes, 60: 200–208, 2011.
49.
FarrRL, LismontC, TerleckySR, and FransenM. Peroxisome biogenesis in mammalian cells: the impact of genes and environment. Biochim Biophys Acta, 1863: 1049–1060, 2016.
50.
FechnerA, BöhmeC, GromerS, FunkM, SchirmerR, and BeckerK. Antioxidant status and nitric oxide in the malnutrition syndrome kwashiorkor. Pediatr Res, 49: 237–243, 2001.
51.
FourcadeS, López-ErauskinJ, GalinoJ, DuvalC, NaudiA, JoveM, KempS, VillarroyaF, FerrerI, PamplonaR, Portero-OtinM, and PujolA. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. Hum Mol Genet, 17: 1762–1773, 2008.
52.
FranciscoT, RodriguesTA, PintoMP, CarvalhoAF, AzevedoJE, and GrouCP. Ubiquitin in the peroxisomal protein import pathway. Biochimie, 98: 29–35, 2013.
FransenM, NordgrenM, WangB, and ApanasetsO. Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim Biophys Acta, 1822: 1363–1373, 2012.
55.
FransenM, NordgrenM, WangB, ApanasetsO, and Van VeldhovenPP. Aging, age-related diseases and peroxisomes. Subcell Biochem, 69: 45–65, 2013.
56.
FrederiksWM, BoschKS, HoebenKA, van MarleJ, and LangbeinS. Renal cell carcinoma and oxidative stress: the lack of peroxisomes. Acta Histochem, 112: 364–371, 2010.
57.
GehrmannW, WürdemannW, PlötzT, JörnsA, LenzenS, and ElsnerM. Antagonism between saturated and unsaturated fatty acids in ROS mediated lipotoxicity in rat insulin-producing cells. Cell Physiol Biochem, 36: 852–865, 2015.
58.
GiordanoCR and TerleckySR. Peroxisomes, cell senescence, and rates of aging. Biochim Biophys Acta, 1822: 1358–1362, 2012.
59.
GlorieuxC, DejeansN, SidB, BeckR, CalderonPB, and VerraxJ. Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem Pharmacol, 82: 1384–1390, 2011.
60.
GodoS and ShimokawaH. Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis. Free Radic Biol Med, 109: 4–10, 2017.
61.
GóthL and NagyT. Inherited catalase deficiency: is it benign or a factor in various age related disorders?. Mutat Res, 753: 147–154, 2013.
62.
GrayE, GintyM, KempK, ScoldingN, and WilkinsA. Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function. Eur J Neurosci, 33: 1421–1432, 2011.
63.
GrayTJ, LakeBG, BeamandJA, FosterJR, and GangolliSD. Peroxisomal effects of phthalate esters in primary cultures of rat hepatocytes. Toxicology, 28: 167–179, 1983.
64.
GutscherM, PauleauAL, MartyL, BrachT, WabnitzGH, SamstagY, MeyerAJ, and DickTP. Real-time imaging of the intracellular glutathione redox potential. Nat Methods, 5: 553–559, 2008.
65.
GutscherM, SobottaMC, WabnitzGH, BallikayaS, MeyerAJ, SamstagY, and DickTP. Proximity-based protein thiol oxidation by H2O2-scavenging peroxidases. J Biol Chem, 284: 31532–31540, 2009.
66.
HamanakaRB and ChandelNS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci, 35: 505–513, 2010.
67.
HanschmannEM, GodoyJR, BerndtC, HudemannC, and LilligCH. Thioredoxins, glutaredoxins, and peroxiredoxins–Molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal, 19: 1539–1605, 2013.
68.
HansonGT, AggelerR, OglesbeeD, CannonM, CapaldiRA, TsienRY, and RemingtonSJ. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem, 279: 13044–13053, 2004.
69.
HasegawaK, WakinoS, YoshiokaK, TatematsuS, HaraY, MinakuchiH, SueyasuK, WashidaN, TokuyamaH, TzukermanM, SkoreckiK, HayashiK, and ItohH. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function. J Biol Chem, 285: 13045–13056, 2010.
IvashchenkoO, Van VeldhovenPP, BreesC, HoYS, TerleckySR, and FransenM. Intraperoxisomal redox balance in mammalian cells: oxidative stress and interorganellar cross-talk. Mol Biol Cell, 22: 1440–1451, 2011.
76.
JoDS, BaeDJ, ParkSJ, SeoHM, KimHB, OhJS, ChangJW, KimSY, ShinJW, and ChoDH. Pexophagy is induced by increasing peroxisomal reactive oxygen species in 1'10-phenanthroline-treated cells. Biochem Biophys Res Commun, 467: 354–360, 2015.
77.
KarlssonM, KurzT, BrunkUT, NilssonSE, and FrennessonCI. What does the commonly used DCF test for oxidative stress really show?. Biochem J, 428: 183–190, 2010.
78.
KasaiH, OkadaY, NishimuraS, RaoMS, and ReddyJK. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxsome proliferator. Cancer Res, 49: 2603–2605, 1989.
79.
KaulN and AliS. Genes, genetics, and environment in type 2 diabetes: implication in personalized medicine. DNA Cell Biol, 35: 1–12, 2016.
80.
KazmierczakM, KazmierczakP, PengAW, HarrisSL, ShahP, PuelJL, LenoirM, FrancoSJ, and SchwanderM. Pejvakin, a candidate stereociliary rootlet protein, regulates hair cell function in a cell-autonomous manner. J Neurosci, 37: 3447–3464, 2017.
81.
KempS, WeiHM, LuJF, BraitermanLT, McGuinnessMC, MoserAB, WatkinsPA, and SmithKD. Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy. Nat Med, 4: 1261–1268, 1998.
82.
KharroubiI, LadrièreL, CardozoAK, DogusanZ, CnopM, and EizirikDL. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology, 145: 5087–5096, 2004.
83.
KimJH, SongJ, and ParkKW. The multifaceted factor peroxisome proliferator-activated receptor γ (PPARγ) in metabolism, immunity, and cancer. Arch Pharm Res, 38: 302–312, 2015.
84.
KirkmanHN and GaetaniGF. Mammalian catalase: a venerable enzyme with new mysteries. Trends Biochem Sci, 32: 44–50, 2007.
85.
KitajiriS, SakamotoT, BelyantsevaIA, GoodyearRJ, StepanyanR, FujiwaraI, BirdJE, RiazuddinS, RiazuddinS, AhmedZM, HinshawJE, SellersJ, BartlesJR, and HammerJA3rd, RichardsonGP, GriffithAJ, FrolenkovGI, and FriedmanTB. Actin-bundling protein TRIOBP forms resilient rootlets of hair cell stereocilia essential for hearing. Cell, 141: 786–798, 2010.
86.
KnoopsB, ArgyropoulouV, BeckerS, FertéL, and KuznetsovaO. Multiple Roles of Peroxiredoxins in Inflammation. Mol Cells, 39: 60–64, 2016.
87.
KnoopsB, GoemaereJ, Van der EeckenV, and DeclercqJP. Peroxiredoxin 5: structure, mechanism, and function of the mammalian atypical 2-Cys peroxiredoxin. Antioxid Redox Signal, 15: 817–829, 2011.
88.
KoepkeJI, NakriekoKA, WoodCS, BoucherKK, TerleckyLJ, WaltonPA, and TerleckySR. Restoration of peroxisomal catalase import in a model of human cellular aging. Traffic, 8: 1592–1600, 2007.
89.
KoepkeJI, WoodCS, TerleckyLJ, WaltonPA, and TerleckySR. Progeric effects of catalase inactivation in human cells. Toxicol Appl Pharmacol, 232: 99–108, 2008.
90.
KovacsWJ, TapeKN, ShackelfordJE, WikanderTM, RichardsMJ, FlieslerSJ, KrisansSK, and FaustPL. Peroxisome deficiency causes a complex phenotype because of hepatic SREBP/Insig dysregulation associated with endoplasmic reticulum stress. J Biol Chem, 284: 7232–7245, 2009.
91.
LauerC, VolklA, RiedlS, FahimiHD, and BeierK. Impairment of peroxisomal biogenesis in human colon carcinoma. Carcinogenesis, 20: 985–989, 1999.
92.
LaurindoFR, FernandesDC, and SantosCX. Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products. Methods Enzymol, 441: 237–260, 2008.
93.
LefevreSD, van RoermundCW, WandersRJ, VeenhuisM, and van der KleiIJ. The significance of peroxisome function in chronological aging of Saccharomyces cerevisiae. Aging Cell, 12: 784–793, 2013.
94.
LegakisJE, KoepkeJI, JedeszkoC, BarlaskarF, TerleckyLJ, EdwardsHJ, WaltonPA, and TerleckySR. Peroxisome senescence in human fibroblasts. Mol Biol Cell, 13: 4243–4255, 2002.
95.
LennickeC, RahnJ, LichtenfelsR, WessjohannLA, and SeligerB. Hydrogen peroxide- production, fate and role in redox signaling of tumor cells. Cell Commun Signal, 13: 39, 2015.
96.
LiX, ChenH, and EpsteinPN. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells. Diabetes, 55: 1592–1604, 2006.
97.
LiY, TharappelJC, CooperS, GlennM, GlauertHP, and SpearBT. Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kB. DNA Cell Biol, 19: 113–120, 2000.
LimJB, LangfordTF, HuangBK, DeenWM, and SikesHD. A reaction-diffusion model of cytosolic hydrogen peroxide. Free Radic Biol Med, 90: 85–90, 2016.
100.
LismontC, NordgrenM, BreesC, KnoopsB, Van VeldhovenPP, and FransenM. Peroxisomes as modulators of cellular protein thiol oxidation: a new model system. Antioxid Redox Signal, 30: 22–39, 2018.
101.
LismontC, NordgrenM, Van VeldhovenPP, and FransenM. Redox interplay between mitochondria and peroxisomes. Front Cell Dev Biol, 3: 35, 2015.
102.
LismontC, WaltonPA, and FransenM. Quantitative monitoring of subcellular redox dynamics in living mammalian cells using RoGFP2-based probes. Methods Mol Biol, 1595: 151–164, 2017.
103.
LodhiIJ and SemenkovichCF. Peroxisomes: a nexus for lipid metabolism and cellular signaling. Cell Metab, 19: 380–392, 2014.
104.
López-ErauskinJ, GalinoJ, BianchiP, FourcadeS, AndreuAL, FerrerI, Muñoz-PinedoC, and PujolA. Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy. Brain, 135: 3584–3598, 2012.
105.
López-ErauskinJ, GalinoJ, RuizM, CuezvaJM, FabregatI, CacabelosD, BoadaJ, MartínezJ, FerrerI, PamplonaR, VillarroyaF, Portero-OtínM, FourcadeS, and PujolA. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linkedadrenoleukodystrophy. Hum Mol Genet, 2013: 3296–3305, 2013.
106.
ManaryMJ, LeeuwenburghC, and HeineckeJW. Increased oxidative stress in kwashiorkor. J Pediatr, 137: 421–424, 2000.
107.
MardonesP and HetzC. Peroxisomes get loud: a redox antidote to hearing loss. Cell, 163: 790–791, 2015.
108.
MarengoB, NittiM, FurfaroAL, CollaR, CiucisCD, MarinariUM, PronzatoMA, TraversoN, and DomenicottiC. Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy. Oxid Med Cell Longev, 2016: 6235641, 2016.
109.
MargoliashE, NovogrodskyA, and SchejterA. Irreversible reaction of 3-amino-1,2,4-triazole and related inhibitors with the protein of catalase. Biochem J, 74: 339–348, 1960.
110.
McClellandGB, KhannaS, GonzálezGF, ButzCE, and BrooksGA. Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system. Biochem Biophys Res Commun, 304: 130–135, 2003.
111.
MinXL, WangTY, CaoY, LiuJ, LiJT, and WangTH. MicroRNAs: a novel promising therapeutic target for cerebral ischemia/reperfusion injury?. Neural Regen Res, 10: 1799–1808, 2015.
112.
MisraP, ViswakarmaN, and ReddyJK. Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis. Subcell Biochem, 69: 77–99, 2013.
113.
MitchellAM, BridgesJW, and ElcombeCR. Factors influencing peroxisome proliferation in cultured rat hepatocytes. Arch Toxicol, 55: 239–246, 1984.
114.
MoritaA, TanimotoK, MurakamiT, MorinagaT, and HosoiY. Mitochondria are required for ATM activation by extranuclear oxidative stress in cultured human hepatoblastoma cell line Hep G2 cells. Biochem Biophys Res Commun, 443: 1286–1290, 2014.
115.
MullerM. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal, 11: 59–98, 2009.
116.
MüllerCC, NguyenTH, AhlemeyerB, MeshramM, SantrampurwalaN, CaoS, SharpP, FietzPB, Baumgart-VogtE, and CraneDI. PEX13 deficiency in mouse brain as a model of Zellweger syndrome: abnormal cerebellum formation, reactive gliosis and oxidative stress. Dis Model Mech, 4: 104–119, 2011.
117.
NauseefWM. Detection of superoxide anion and hydrogen peroxide production by cellular NADPH oxidases. Biochim Biophys Acta, 1840: 757–767, 2014.
118.
NettoLE and AntunesF. The roles of peroxiredoxin and thioredoxin in hydrogen peroxide sensing and in signal transduction. Mol Cells, 39: 65–71, 2016.
119.
NeubergerG, Maurer-StrohS, EisenhaberB, HartigA, and EisenhaberF. Motif refinement of the peroxisomal targeting signal 1 and evaluation of taxon-specific differences. J Mol Biol, 328: 567–579, 2003.
120.
NordgrenM and FransenM. Peroxisomal metabolism and oxidative stress. Biochimie, 98: 56–62, 2014.
121.
NordgrenM, FranciscoT, LismontC, HennebelL, BreesC, WangB, Van VeldhovenPP, AzevedoJE, and FransenM. Export-deficient monoubiquitinated PEX5 triggers peroxisome removal in SV40 large T antigen-transformed mouse embryonic fibroblasts. Autophagy, 11: 1326–1340, 2015.
122.
NordgrenM, WangB, ApanasetsO, and FransenM. Peroxisome degradation in mammals: mechanisms of action, recent advances, and perspectives. Front Physiol, 4: 145, 2013.
123.
OkamotoM, ReddyJK, and OyasuR. Tumorigenic conversion of a non-tumorigenic rat urothelial cell line by overexpression of H2O2-generating peroxisomal fatty acyl-CoA oxidase. Int J Cancer, 70: 716–721, 1997.
124.
OkuM and SakaiY. Assessment of physiological redox state with novel FRET protein probes. Antioxid Redox Signal, 16: 698–704, 2012.
125.
OkumotoK, NodaH, and FujikiY. Distinct modes of ubiquitination of peroxisome-targeting signal type 1 (PTS1) receptor Pex5p regulate PTS1 protein import. J Biol Chem, 289: 14089–14108, 2014.
126.
OlowookereJO, OlorunsogoOO, and MalomoSO. Effects of defective in vivo synthesis of mitochondrial proteins on cellular biochemistry and physiology of malnourished rats. Ann Nutr Metab, 34: 147–154, 1990.
127.
OnumahOE, JulesGE, ZhaoY, ZhouL, YangH, and GuoZ. Overexpression of catalase delays G0/G1- to S-phase transition during cell cycle progression in mouse aortic endothelial cells. Free Radic Biol Med, 46: 1658–1667, 2009.
128.
OruqajG, KarnatiS, VijayanV, KotarkondaLK, BoatengE, ZhangW, RuppertC, GüntherA, ShiW, and Baumgart-VogtE. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling. Proc Natl Acad Sci USA, 112: E2048–E2057, 2015.
129.
PaceNJ and WeerapanaE. Diverse functional roles of reactive cysteines. ACS Chem Biol, 8: 283–296, 2013.
130.
PacherP, BeckmanJS, and LiaudetL. Nitric oxide and peroxynitrite in health and disease. Physiol Rev, 87: 315–424, 2007.
131.
PackerL, WittEH, and TritschlerHJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med, 19: 227–250, 1995.
132.
PaulsenCE and CarrollKS. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem Rev, 113: 4633–4679, 2013.
133.
PawlakM, LefebvreP, and StaelsB. Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol, 62: 720–733, 2015.
134.
PeetersA, ShindeAB, DirkxR, SmetJ, De BockK, EspeelM, VanhorebeekI, VanlanderA, Van CosterR, CarmelietP, FransenM, Van VeldhovenPP, and BaesM. Mitochondria in peroxisome-deficient hepatocytes exhibit impaired respiration, depleted DNA, and PGC-1α independent proliferation. Biochim Biophys Acta, 1853: 285–298, 2015.
135.
PetrivOI and RachubinskiRA. Lack of peroxisomal catalase causes a progeric phenotype in Caenorhabditis elegans. J Biol Chem, 279: 19996–20001, 2004.
136.
PrinzenFW, Van der VusseGJ, ArtsT, RoemenTH, CoumansWA, and RenemanRS. Accumulation of nonesterified fatty acids in ischemic canine myocardium. Am J Physiol, 247: H264–H272, 1984.
137.
PurduePE and LazarowPB. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J Cell Biol, 134: 849–862, 1996.
ReddyJK, AzarnoffDL, and HigniteCE. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature, 283: 397–398, 1980.
140.
RokkaA, AntonenkovVD, SoininenR, ImmonenHL, PiriläPL, BergmannU, SormunenRT, WeckströmM, BenzR, and HiltunenJK. Pxmp2 is a channel-forming protein in mammalian peroxisomal membrane. PLoS One, 4: e5090, 2009.
141.
RomaLP, DuprezJ, TakahashiHK, GilonP, WiederkehrA, and JonasJC. Dynamic measurements of mitochondrial hydrogen peroxide concentration and glutathione redox state in rat pancreatic β-cells using ratiometric fluorescent proteins: confounding effects of pH with HyPer but not roGFP1. Biochem J, 441: 971–978, 2012.
142.
RudykO and EatonP. Biochemical methods for monitoring protein thiol redox in biological systems. Redox Biol, 2: 803–813, 2014.
143.
Ruiz-OjedaFJ, Gomez-LlorenteC, AguileraCM, GilA, and RupérezAI. Impact of 3-amino-1,2,4-triazole (3-AT)-derived increase in hydrogen peroxide levels on inflammation and metabolism in human differentiated adipocytes. PLoS One, 11: e0152550, 2016.
144.
RusnakF and ReiterT. Sensing electrons: protein phosphatase redox regulation. Trends Biochem Sci, 25: 527–529, 2000.
145.
SantanamN, AugN, ZhouM, KeshavaC, and ParthasarathyS. Overexpression of human catalase gene decreases oxidized lipid-induced cytotoxicity in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 19: 1912–1917, 1999.
146.
SantosMJ, QuintanillaRA, ToroA, GrandyR, DinamarcaMC, GodoyJA, and InestrosaNC. Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J Biol Chem, 280: 41057–41068, 2005.
147.
Scherz-ShouvalR, ShvetsE, FassE, ShorerH, GilL, and ElazarZ. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J, 26: 1749–1760, 2007.
148.
SchieberM and ChandelNS. ROS function in redox signaling and oxidative stress. Curr Biol, 24: R453–R462, 2014.
149.
SchraderM, CostelloJL, GodinhoLF, AzadiAS, and IslingerM. Proliferation and fission of peroxisomes–an update. Biochim Biophys Acta, 1863: 971–983, 2016.
150.
SchrinerSE, SmithAC, DangNH, FukuchiK, and MartinGM. Overexpression of wild-type and nuclear-targeted catalase modulates resistance to oxidative stress but does not alter spontaneous mutant frequencies at APRT. Mutat Res, 449: 21–31, 2000.
151.
SchwarzländerM, DickTP, MeyerAJ, and MorganB. Dissecting Redox Biology Using Fluorescent Protein Sensors. Antioxid Redox Signal, 24: 680–712, 2016.
152.
SenaLA and ChandelNS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell, 48: 158–167, 2012.
153.
ShaiN, SchuldinerM, and ZalckvarE. No peroxisome is an island - Peroxisome contact sites. Biochim Biophys Acta, 1863: 1061–1069, 2016.
154.
SiesH. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol, 11: 613–619, 2017.
155.
SinghAK, DhaunsiGS, GuptaMP, OrakJK, AsayamaK, and SinghI. Demonstration of glutathione peroxidase in rat liver peroxisomes and its intraorganellar distribution. Arch Biochem Biophys, 315: 331–338, 1994.
156.
SinghI, SinghAK, and ContrerasMA. Peroxisomal dysfunction in inflammatory childhood white matter disorders: an unexpected contributor to neuropathology. J Child Neurol, 24: 1147–1157, 2009.
157.
SohS, ByrskaM, Kandere-GrzybowskaK, and GrzybowskiBA. Reaction-diffusion systems in intracellular molecular transport and control. Angew Chem Int Ed Engl, 49: 4170–4198, 2010.
158.
SyedDN and MukhtarH. Gender bias in skin cancer: role of catalase revealed. J Invest Dermatol, 132: 512–514, 2012.
159.
TerleckySR, KoepkeJI, and WaltonPA. Peroxisomes and aging. Biochim Biophys Acta, 1763: 1749–1754, 2006.
TureckýL, KupčováV, UhlíkováE, and MojtoV. Peroxisomal enzymes in the liver of rats with experimental diabetes mellitus type 2. Physiol Res, 63: S585–S591, 2014.
162.
ValençaI, Pértega-GomesN, VizcainoJR, HenriqueRM, LopesC, BaltazarF, and RibeiroD. Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer. J Cell Mol Med, 19: 723–733, 2015.
163.
van der VlietA and Janssen-HeiningerYM. Hydrogen peroxide as a damage signal in tissue injury and inflammation: murderer, mediator, or messenger?. J Cell Biochem, 115: 427–435, 2014.
164.
Van VeldhovenPP. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res, 51: 2863–2895, 2010.
165.
van ZutphenT, CiapaiteJ, BloksVW, AckereleyC, GerdingA, JurdzinskiA, de MoraesRA, ZhangL, WoltersJC, BischoffR, WandersRJ, HoutenSM, Bronte-TinkewD, ShatsevaT, LewisGF, GroenAK, ReijngoudDJ, BakkerBM, JonkerJW, KimPK, and BandsmaRH. Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunction. J Hepatol, 65: 1198–1208, 2016.
WadleyAJ, AldredS, and ColesSJ. An unexplored role for peroxiredoxin in exercise-induced redox signalling?. Redox Biol, 8: 51–58, 2016.
168.
WalbrecqG, WangB, BeckerS, HannotiauA, FransenM, and KnoopsB. Antioxidant cytoprotection by peroxisomal peroxiredoxin-5. Free Radic Biol Med, 84: 215–226, 2015.
169.
WaliG, SutharsanR, FanY, StewartR, Tello VelasquezJ, SueCM, CraneDI, and Mackay-SimA. Mechanism of impaired microtubule-dependent peroxisome trafficking and oxidative stress in SPAST-mutated cells from patients with Hereditary Spastic Paraplegia. Sci Rep, 6: 27004, 2016.
170.
WalterKM, SchönenbergerMJ, TrötzmüllerM, HornM, ElsässerHP, MoserAB, LucasMS, SchwarzT, GerberPA, FaustPL, MochH, KöfelerHC, KrekW, and KovacsWJ. Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy. Cell Metab, 20: 882–897, 2014.
171.
WaltonPA and PizzitelliM. Effects of peroxisomal catalase inhibition on mitochondrial function. Front Physiol, 3: 108, 2012.
172.
WandersRJ and WaterhamHR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem, 75: 295–332, 2006.
173.
WangB, ApanasetsO, NordgrenM, and FransenM. Dissecting peroxisome-mediated signaling pathways: a new and exciting research field. In: Molecular Machines Involved in Peroxisome Biogenesis and Maintenance, edited by BrocardC and HartigA. Austria: Springer-Verlag Wien, 2014, Chapter 11, pp. 255–273.
174.
WangB, Van VeldhovenPP, BreesC, RubioN, NordgrenM, ApanasetsO, KunzeM, BaesM, AgostinisP, and FransenM. Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells. Free Radic Biol Med, 65: 882–894, 2013.
175.
WaterhamHR, FerdinandusseS, and WandersRJ. Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta, 1863: 922–933, 2016.
176.
WengH, JiX, EndoK, and IwaiN. Pex11α deficiency is associated with a reduced abundance of functional peroxisomes and aggravated renal interstitial lesions. Hypertension, 64: 1054–1060, 2014.
177.
WinterbournCC. The challenges of using fluorescent probes to detect and quantify specific reactive oxygen species in living cells. Biochim Biophys Acta, 1840: 730–738, 2014.
YangY, SongY, and LoscalzoJ. Regulation of the protein disulfide proteome by mitochondria in mammalian cells. Proc Natl Acad Sci USA, 104: 10813–10817, 2007.
180.
YanoT, OkuM, AkeyamaN, ItoyamaA, YurimotoH, KugeS, FujikiY, and SakaiY. A novel fluorescent sensor protein for visualization of redox states in the cytoplasm and in peroxisomes. Mol Cell Biol, 30: 3758–3766, 2010.
YeldandiAV, RaoMS, and ReddyJK. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat Res, 448: 159–177, 2000.
183.
YoungCN, KoepkeJI, TerleckyLJ, BorkinMS, Boyd SavoyL, and TerleckySR. Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol, 128: 2606–2614, 2008.
184.
ZhaS, FerdinandusseS, HicksJL, DenisS, DunnTA, WandersRJ, LuoJ, De MarzoAM, and IsaacsWB. Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer. Prostate, 63: 316–323, 2005.
185.
ZhangJ, KimJ, AlexanderA, CaiS, TripathiDN, DereR, TeeAR, Tait-MulderJ, Di NardoA, HanJM, KwiatkowskiE, DunlopEA, DoddKM, FolkerthRD, FaustPL, KastanMB, SahinM, and WalkerCL. A tuberous sclerosis complex signaling node at the peroxisome regulates mTORC1 and autophagy in response to ROS. Nat Cell Biol, 15: 1186–1196, 2013.
186.
ZhangJ, TripathiDN, JingJ, AlexanderA, KimJ, PowellRT, DereR, Tait-MulderJ, LeeJH, PaullTT, PanditaRK, CharakaVK, PanditaTK, KastanMB, and WalkerCL. ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat Cell Biol, 17: 1259–1269, 2015.
187.
ZitoE. ERO1: a protein disulfide oxidase and H2O2 producer. Free Radic Biol Med, 83: 299–304, 2015.
